IM Medic
ActiveSummary
IM Medic has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €160k and a net result of €155k. Equity is growing by ~32.5% per year across the filed fiscal years. Its solvency ranks better than 19% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
75
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency51▼-49
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11k at 30 days acceptable
Liquidity tight (current ratio 1.34 against 24.54 in 2023; short-term debt: 72.3% and cash: 24.9% of total assets), and 73.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 19908 sector peers (2024).
NBB · sector comparisonPosition among 19908 sector peers
Solvency
better than 19%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-07-2025, 2 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
not confirmed
2024
2 d early
2023
5 d early
2022
28 d early
2021
32 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€160k▼ 62.2%
2023 · €423k
2021: €128k
2022: €288k
2023: €423k
2021 → 2024
Total assets
€604k▲ 30.9%
2023 · €462k
2021: €198k
2022: €328k
2023: €462k
2021 → 2024
Net result
€155k▲ 14.6%
2023 · €135k
2021: €123k
2022: €159k
2023: €135k
2021 → 2024
Working capital
€146k▼ 65.0%
2023 · €418k
2021: €121k
2022: €279k
2023: €418k
2021 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2021202220232024Trend
Equity€128k-€288k▲ 124%€423k▲ 46.9%€160k▼ 62.2%
Operating result€165k-€207k▲ 25.6%€175k▼ 15.3%€188k▲ 7.3%
Net result€123k-€159k▲ 29.1%€135k▼ 15.2%€155k▲ 14.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 7% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €604k
Fixed assets
€21k ▼ 17.5%
Current assets
€583k ▲ 33.8%
Equity and liabilities €604k
Equity
€160k ▼ 62.2%
Debt
€444k ▲ 1,044%
Debt's share of the balance-sheet total rises from 8.4% to 73.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€197k▲
2023 · €184k
Cash flow
€164k▲
2023 · €144k
Current ratio
1.34▼
2023 · 24.54
Debt to equity
2.78▲
2023 · 0.09
ROE
96.9%▲
2023 · 31.9%
ROA
25.6%▼
2023 · 29.3%
Interest coverage
274.93▼
2023 · 326.44
Debt ≤ 1 year
€437k▲
2023 · €18k
Debt > 1 year
€8k▼
2023 · €17k
Income taxes
€47k▲
2023 · €39k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 45 lines
Balance sheet
Code20232024
Assets
Total assets20/58€462k€604k▲
Fixed assets21/28€26k€21k▼
Tangible fixed assets22/27€26k€21k▼
Plant, machinery and equipment23-€989
Furniture and vehicles24€26k€20k▼
Current assets29/58€436k€583k▲
Amounts receivable within one year40/41€11k€269k▲
Other amounts receivable41€11k€269k▲
Current investments50/53€150k€150k=
Cash at bank and in hand54/58€217k€151k▼
Deferred charges and accrued income490/1€58k€14k▼
Equity and liabilities
Total equity and liabilities10/49€462k€604k▲
Equity10/15€423k€160k▼
Contributions10/11€5k€5k=
Reserves13€418k€155k▼
Distributable reserves133€418k€155k▼
Amounts payable17/49€39k€444k▲
Amounts payable after more than one year17€17k€8k▼
Financial debts170/4€17k€8k▼
Amounts payable within one year42/48€18k€437k▲
Current portion of amounts payable after more than one year42€9k€9k▲
Trade debts44€4k€4k▲
Suppliers440/4€4k€4k▲
Taxes, remuneration and social security45€3k€6k▲
Taxes450/3€3k€6k▲
Other amounts payable47/48€2k€418k▲
Accrued charges and deferred income492/3€4k-
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€10k▲
Other operating charges640/8€376€460▲
Gross operating margin9900€185k€198k▲
Operating profit (loss)9901€175k€188k▲
Financial income75/76B€17€15k▲
Recurring financial income75€17€15k▲
Financial charges65/66B€564€718▲
Recurring financial charges65€564€718▲
Profit (loss) for the period before taxes9903€174k€202k▲
Income taxes67/77€39k€47k▲
Profit (loss) for the period9904€135k€155k▲
Profit (loss) for the period to be appropriated9905€135k€155k▲
Appropriation of the result
Profit (loss) to be appropriated9906€135k€155k▲
Transfer from equity791/2-€418k
Transfer to equity691/2€135k€155k▲
To other reserves6921€135k€155k▲
Profit to be distributed694/7-€418k
Return on contributions (dividend)694-€418k
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
26-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
03-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Highest result since 2021net €159k ▲29.1%
Operating result €207k, net result €159k, both a record.
31-12
Financial
Liquidity times 5current ratio 21.89
Current ratio from 4.59 to 21.89; short-term debt falls from €34k to €13k.
31-12
Financial
Equity above €200kEq €288k ▲124%
2 profitable years in a row build equity to €288k.
29-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zoersel · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Wandelweg 672980 ZoerselGround area
1,753 m²
Building footprint
149 m²
Volume, LiDAR
1,084 m³
Parcel 11017A0501/00A000, Flanders · tallest building 11.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
IM Medic
since 20212.317.337.720
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11017A0501/00A000 | Flanders | 1,753 m² | 1 · 149 m² | 11.5 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
JEPELIS
BE 0828.620.520
Hoeilaart · Eq €159,881
LEBOUT'CHOU
BE 0773.347.841
Sint-Pieters-Woluwe · Eq €159,933
SOCIETE MEDICO-CHIRURGICALE L'ECTODERME
BE 0562.894.661
Colfontaine · Eq €159,580
Dr. Yves Spysschaert
BE 0681.979.185
Genk · Eq €159,576
CaroDcf
BE 0803.432.489
Ottignies-Louvain-la-Neuve · Eq €159,445
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,774 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-05-2021
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.